É. Inserm, Un ensemble de maladies complexe, encore mal compris, 2018.

R. S. Fisher and C. Acevedo, ILAE Official Report: A Practical Clinical Definition of Epilepsy, Epilepsia, vol.55, issue.4, pp.475-82, 2014.

, Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia, vol.30, pp.389-99, 1989.

I. E. Scheffer and S. Berkovic, ILAE Classification of the Epilepsies: Position Paper of the ILAE Commission for Classification and Terminology, Epilepsia, vol.58, issue.4, pp.512-521, 2017.

O. Egunsola and I. Choonara, Anti-Epileptic Drug Utilisation in Paediatrics: A Systematic Review, BMJ Paediatrics, vol.1, issue.1, 2017.

F. T. Bourgeois, K. L. Olson, and A. Poduri, Comparison of Drug Utilization Patterns in Observational Data: Antiepileptic Drugs in Pediatric Patients, Paediatr Drugs, vol.17, issue.5, pp.401-411, 2015.

J. H. Diliberti, P. A. Farndon, and N. R. Dennis, The fetal valproate syndrome, Am J Med Genet, vol.19, issue.3, pp.473-81, 1984.

C. Donnai and D. , Fetal valproate syndrome, J Med Genet, vol.32, issue.9, pp.724-731, 1995.

C. L. Harden, K. J. Meador, and P. B. Pennell, Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes, Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the, 2009.

T. Tomson, D. Battino, and E. Bonizzoni, Dose-dependent teratogenicity of valproate in mono-and polytherapy: an observational study, Neurology, 2015.

, Sep, vol.8, issue.10, pp.866-72

T. Tomson, D. Battino, and E. Bonizzoni, Withdrawal of valproic acid treatment during pregnancy and seizure outcome: Observations from EURAP, Epilepsia, vol.57, issue.8, pp.173-180, 2016.

J. Weston and R. Bromley, Monotherapy Treatment of Epilepsy in Pregnancy: Congenital Malformation Outcomes in the Child ». Édité par Cochrane Epilepsy Group, Cochrane Database of Systematic Reviews, vol.11, p.10224, 2016.

N. Adab, U. Kini, and J. Vinten, The longer term outcome of children born to mothers with epilepsy, J Neurol Neurosurg Psychiatry, vol.75, issue.11, pp.1575-83, 2004.

K. J. Meador, G. A. Baker, and N. Browning, Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study, Lancet Neurol, vol.12, issue.3, pp.244-52, 2013.

R. Bromley, The treatment of epilepsy in pregnancy: The neurodevelopmental risks associated with exposure to antiepileptic drugs, Reprod Toxicol, vol.64, pp.203-213, 2016.

J. Christensen, T. K. Grønborg, and M. J. Sørensen, Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism, JAMA, vol.309, issue.16, pp.1696-703, 2013.

, Haute Autorité de Santé. Filles, adolescentes, femmes en âge de procréer et femmes enceintes ayant une épilepsie : spécialités à base de valproate et alternatives médicamenteuses, 2015.

, Nouvelles conditions de prescription et de délivrance des spécialités à base de valproate et dérivés du fait des risques liés à leur utilisation pendant la grossesse, Agence nationale de sécurité du médicament et des produits de santé (ANSM), 2015.

T. Tomson and A. Marson, Valproate in the Treatment of Epilepsy in Girls and Women of Childbearing Potential, Epilepsia, 2015.

, Risque de troubles neuro-développementaux précoces (avant l'âge de 6 ans) associé à l'exposition in utero à l'acide valproïque et aux autres traitements de l'épilepsie en France, Agence nationale de sécurité du médicament et des produits de santé (ANSM), 2018.

D. A. Wilson, W. Et-anbesaw, and . Selassie, Risk of Severe and Repetitive Traumatic Brain Injury in Persons with Epilepsy: A Population-Based Case-Control Study, Epilepsy & Behavior, vol.32, pp.42-50, 2014.

B. Abarrategui and B. Parejo-carbonell, The Cognitive Phenotype of Idiopathic Generalized Epilepsy, Epilepsy & Behavior, vol.89, pp.99-104, 2018.

C. Cheung and E. Wirrell, Adolescents' perception of epilepsy compared with other chronic diseases: "through a teenager's eyes, J Child Neurol, 2006.

R. Mohanraj, M. J. Et, and . Brodie, Outcomes of Newly Diagnosed Idiopathic Generalized Epilepsy Syndromes in a Non-Pediatric Setting, Acta Neurol Scand, vol.115, issue.3, pp.204-212, 2007.

J. P. Szaflarski, J. Christopher, and . Lindsell, Seizure Control in Patients with Idiopathic Generalized Epilepsies: EEG Determinants of Medication Response, Epilepsy & Behavior, vol.17, issue.4, pp.525-555, 2010.

B. J. Vorderwülbecke, B. Alexander, and . Kowski, Long-Term Outcome in Adolescent-Onset Generalized Genetic Epilepsies, Epilepsia Epilepsia, 2017.

J. Christensen and M. J. Kjeldsen, Gender Differences in Epilepsia, vol.46, pp.956-60, 2005.

, The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. London: National Institute for Clinical Excellence, Clinical Guideline, vol.28, p.20, 2012.

T. Glauser, E. Ben-menachem, and B. Bourgeois, ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes, Epilepsia, 2006.

V. Biton, G. D. Montouris, and F. Ritter, Placebo-Controlled Study of Topiramate in Primary Generalized Tonic-Clonic Seizures, Neurology, vol.52, issue.7, pp.1330-1337, 1999.

V. Biton, J. Sackellares, and . Vuong, CME Double-Blind, Placebo-Controlled Study of Lamotrigine in Primary Generalized Tonic-Clonic Seizures Neurology, vol.65, pp.1737-1780, 2005.

T. Smith, C. Marson, A. G. Williamson, and P. R. , Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures, Cochrane Database Syst Rev, issue.4, 2001.

T. Glauser, A. Cnaan, and S. Shinnar, Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months, Epilepsia, vol.54, issue.1, pp.141-55, 2013.

A. Cnaan, S. Shinnar, and R. Arya, Second monotherapy in childhood absence epilepsy, Neurology, vol.88, issue.2, pp.182-190, 2017.

G. Coppola and G. Auricchio, Lamotrigine versus Valproic Acid as First-Line Monotherapy in Newly Diagnosed Typical Absence Seizures: An Open-Label, Randomized, Parallel-Group Study, Epilepsia, 2004.

A. Nicolson, R. E. Appleton, and D. W. Chadwick, The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies, J Neurol Neurosurg Psychiatry, vol.75, issue.1, pp.75-84, 2004.

V. Giri and . Prakash, Valproic Acid versus Lamotrigine as First-Line Monotherapy in Newly Diagnosed Idiopathic Generalized Tonic -Clonic Seizures in Adults -A Randomized Controlled Trial, J Clin Diagn Res, vol.10, issue.7, pp.1-4, 2016.

A. G. Marson, M. Asya, and . Al-kharusi, The SANAD Study of Effectiveness of Valproate, Lamotrigine, or Topiramate for Generalised and Unclassifiable Epilepsy: An Unblinded Randomised Controlled Trial. The Lancet, vol.369, pp.1016-1042, 2007.

G. Coppola and A. Piccorossi, Anticonvulsant Drugs for Generalized Tonic-Clonic Epilepsy, Expert Opinion on Pharmacotherapy, vol.18, issue.9, pp.925-936, 2017.

S. J. Nevitt, M. Sudell, and J. Weston, Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Cochrane Database Syst Rev, vol.6, p.11412, 2017.

J. Höfler, I. Unterberger, and J. Dobesberger, Seizure outcome in 175 patients with juvenile myoclonic epilepsy--a long-term observational study, Epilepsy Res, vol.108, issue.10, pp.1817-1841, 2014.

K. Singh, Y. D. Shah, and D. Luciano, Safety and efficacy of perampanel in children and adults with various epilepsy syndromes: A single-center postmarketing study, Epilepsy Behav, vol.61, pp.41-45, 2016.

M. Pavlovi?, N. Jovi?, and T. Pekmezovi?, Antiepileptic drugs withdrawal in patients with idiopathic generalized epilepsy, Seizure, vol.20, issue.7, pp.520-525, 2011.

G. Balagura and G. Iapadre, Moving beyond Sodium Valproate: Choosing the Right Anti-Epileptic Drug in Children, Expert Opin Pharmacotherapy, vol.20, issue.12, pp.1449-1456, 2019.

O. Egunsola, I. Choonara, and H. M. Sammons, Safety of lamotrigine in paediatrics: a systematic review, BMJ Open, vol.5, issue.6, 2015.

E. J. Donner and O. C. Snead, New generation anticonvulsants for the treatment of epilepsy in children, NeuroRx, vol.3, issue.2, pp.170-80, 2006.

A. T. Berg, S. Shinnar, and F. M. Testa, Mortality in childhood-onset epilepsy, Arch Pediatr Adolesc Med, vol.158, issue.12, pp.1147-52, 2004.

L. Nashef, E. L. So, P. Ryvlin, and T. Tomson, Unifying the definitions of sudden unexpected death in epilepsy, Epilepsia, vol.53, issue.2, pp.227-260, 2012.

O. Abdel-mannan, H. Taylor, and E. J. Donner, A systematic review of sudden unexpected death in epilepsy (SUDEP) in childhood, Epilepsy Behav, 2019.

C. Harden, T. Tomson, and D. Gloss, Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the, Neurology, vol.88, issue.17, pp.1674-1680, 2017.

K. Nickels, Seizure and Psychosocial Outcomes of Childhood and Juvenile Onset Generalized Epilepsies: Wolf in Sheep's Clothing, or Well-Dressed Wolf? Epilepsy Curr, vol.15, pp.114-121, 2015.

M. Jalava, M. Sillanpää, and C. Camfield, Social adjustment and competence 35 years after onset of childhood epilepsy: a prospective controlled study, Epilepsia, vol.38, issue.6, pp.708-723, 1997.

N. Akanuma and E. Hara, Psychiatric Comorbidity in Adult Patients with Idiopathic Generalized Epilepsy, Epilepsy & Behavior, vol.13, issue.1, pp.248-51, 2008.

A. Jacoby, G. A. Baker, N. Steen, P. Potts, and D. W. Chadwick, The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study, Epilepsia, vol.37, issue.2, pp.148-61, 1996.

R. F. Chin, P. M. Cumberland, and S. S. Pujar, Outcomes of childhood epilepsy at age 33 years: a population-based birth-cohort study, Epilepsia, 2011.

P. R. Camfield and C. S. Camfield, What happens to children with epilepsy when they become adults? Some facts and opinions, Pediatr Neurol, vol.51, issue.1, pp.17-23, 2014.

F. Schneider-von-podewils, C. Gasse, and J. Geithner, Clinical predictors of the long-term social outcome and quality of life in juvenile myoclonic epilepsy: 20-65 years of follow-up, Epilepsia, vol.55, issue.2, pp.322-352, 2014.

, Arrêté du 31 août 2010 modifiant l'arrêté du 21 décembre 2005 fixant la liste des affections médicales incompatibles avec l'obtention

. Texte and . Do, , p.22816662

S. Kaneko, D. Battino, and E. Andermann, Congenital malformations due to antiepileptic drugs, Epilepsy Res, vol.33, issue.2-3, pp.145-58, 1999.

G. Veiby, A. K. Daltveit, and B. A. Engelsen, Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy, J Neurol, vol.261, issue.3, pp.579-88, 2014.

R. Meador and C. , Pregnancy outcomes in women with epilepsy: A systematic review and meta-analysis of published pregnancy registries and cohorts Epilepsy Res, vol.81, pp.1-13, 2008.

S. Hunt, A. Russell, and W. H. Smithson, Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register, Neurology, 2008.

, Jul, vol.22, issue.4, pp.272-278

S. Hernandez-diaz, K. F. Huybrechts, and R. J. Desai, Topiramate use early in pregnancy and the risk of oral clefts: A pregnancy cohort study, Neurology, vol.90, issue.4, pp.342-351, 2018.

, Antiépileptiques au cours de la grossesse : Etat actuel des connaissances sur le risque de malformations et de troubles neurodéveloppementaux, 2019.

, Nouvelle contre-indication pendant la grossesse pour les rétinoïdes utilisés par voie cutanée dans le traitement de l'acné, Agence nationale de sécurité du médicament et des produits de santé (ANSM), vol.25, 2018.

E. Fecond, Ined et l'Inserm, 2010.

. Bilan-démographique, Enquêtes et études démographiques, 2019.

A. Reimers, E. Brodtkorb, and A. Sabers, Interactions between hormonal contraception and antiepileptic drugs: Clinical and mechanistic considerations, Seizure, vol.28, pp.66-70, 2015.

E. B. Samrén, C. M. Van-duijn, and S. Koch, Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy, Epilepsia, vol.38, issue.9, pp.981-90, 1997.

S. Edey, N. Moran, and L. Nashef, SUDEP and epilepsy-related mortality in pregnancy, Epilepsia, vol.55, issue.7, pp.72-74, 2014.

S. C. Macdonald, B. T. Bateman, and T. F. Mcelrath, Mortality and morbidity during delivery hospitalization among pregnant women with epilepsy in the United States, JAMA Neurol, vol.72, issue.9, pp.981-988, 2015.

M. Kellogg, J. Kimford, and . Meador, Neurodevelopmental Effects of Antiepileptic Drugs, Neurochem Res, vol.42, issue.7, pp.2065-2070, 2017.

J. M. Nicholas, L. Ridsdale, and M. P. Richardson, Trends in antiepileptic drug utilisation in UK primary care 1993-2008: cohort study using the General Practice Research Database, Seizure, vol.21, issue.6, pp.466-70, 2012.

, Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia, vol.30, pp.389-99, 1989.

I. E. Scheffer and S. Berkovic, ILAE Classification of the Epilepsies: Position Paper of the ILAE Commission for Classification and Terminology, Epilepsia, vol.58, issue.4, pp.512-521, 2017.

O. Egunsola and I. Choonara, Anti-Epileptic Drug Utilisation in Paediatrics: A Systematic Review, BMJ Paediatrics, vol.1, issue.1, 2017.

F. T. Bourgeois, K. L. Olson, and A. Poduri, Comparison of Drug Utilization Patterns in Observational Data: Antiepileptic Drugs in Pediatric Patients, Paediatr Drugs, vol.17, issue.5, pp.401-411, 2015.

J. H. Diliberti, P. A. Farndon, and N. R. Dennis, The fetal valproate syndrome, Am J Med Genet, vol.19, issue.3, pp.473-81, 1984.

C. Donnai and D. , Fetal valproate syndrome, J Med Genet, vol.32, issue.9, pp.724-731, 1995.

C. L. Harden, K. J. Meador, and P. B. Pennell, Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes, Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the, vol.50, pp.1237-1283, 2009.

T. Tomson, D. Battino, and E. Bonizzoni, Dose-dependent teratogenicity of valproate in mono-and polytherapy: an observational study, Neurology, 2015.

, Sep, vol.8, issue.10, pp.866-72

T. Tomson, D. Battino, and E. Bonizzoni, Withdrawal of valproic acid treatment during pregnancy and seizure outcome: Observations from EURAP, Epilepsia, vol.57, issue.8, pp.173-180, 2016.

J. Weston and R. Bromley, Monotherapy Treatment of Epilepsy in Pregnancy: Congenital Malformation Outcomes in the Child, Cochrane Database of Systematic Reviews, 2016.

, Nov, vol.11, p.10224

N. Adab, U. Kini, and J. Vinten, The longer term outcome of children born to mothers with epilepsy, J Neurol Neurosurg Psychiatry, vol.75, issue.11, pp.1575-83, 2004.

K. J. Meador, G. A. Baker, and N. Browning, Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study, Lancet Neurol, vol.12, issue.3, pp.244-52, 2013.

R. Bromley, The treatment of epilepsy in pregnancy: The neurodevelopmental risks associated with exposure to antiepileptic drugs, Reprod Toxicol, vol.64, pp.203-213, 2016.

J. Christensen, T. K. Grønborg, and M. J. Sørensen, Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism, JAMA, vol.309, issue.16, pp.1696-703, 2013.

, High Authority of Health. Girls, adolescents, women of childbearing age and pregnant women with epilepsy: valproate-based specialities and drug alternatives, 2015.

, New conditions for the prescription and dispensing of specialities based on valproate and derivatives due to the risks associated with their use during pregnancy, 2015.

T. Tomson and A. Marson, Valproate in the Treatment of Epilepsy in Girls and Women of Childbearing Potential, Epilepsia, 2015.

D. A. Wilson, W. Et-anbesaw, and . Selassie, Risk of Severe and Repetitive Traumatic Brain Injury in Persons with Epilepsy: A Population-Based Case-Control Study, Epilepsy & Behavior, vol.32, pp.42-50, 2014.

B. Abarrategui and B. Parejo-carbonell, The Cognitive Phenotype of Idiopathic Generalized Epilepsy, Epilepsy & Behavior, vol.89, pp.99-104, 2018.

C. Cheung and E. Wirrell, Adolescents' perception of epilepsy compared with other chronic diseases: "through a teenager's eyes, J Child Neurol, 2006.

R. Mohanraj, M. J. Et, and . Brodie, Outcomes of Newly Diagnosed Idiopathic Generalized Epilepsy Syndromes in a Non-Pediatric Setting, Acta Neurol Scand, vol.115, issue.3, pp.204-212, 2007.

J. P. Szaflarski, J. Christopher, and . Lindsell, Seizure Control in Patients with Idiopathic Generalized Epilepsies: EEG Determinants of Medication Response, Epilepsy & Behavior, vol.17, issue.4, pp.525-555, 2010.

B. J. Vorderwülbecke, B. Alexander, and . Kowski, Long-Term Outcome in Adolescent-Onset Generalized Genetic Epilepsies, Epilepsia Epilepsia, 2017.

, The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. London: National Institute for Clinical Excellence, Clinical Guideline, p.20, 2012.

A. Nicolson, R. E. Appleton, and D. W. Chadwick, The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies, J Neurol Neurosurg Psychiatry, vol.75, issue.1, pp.75-84, 2004.

A. G. Marson, M. Asya, and . Al-kharusi, The SANAD Study of Effectiveness of Valproate, Lamotrigine, or Topiramate for Generalised and Unclassifiable Epilepsy: An Unblinded Randomised Controlled Trial. The Lancet, vol.369, pp.1016-1042, 2007.

G. Coppola and A. Piccorossi, Anticonvulsant Drugs for Generalized Tonic-Clonic Epilepsy, Expert Opinion on Pharmacotherapy, vol.18, issue.9, pp.925-936, 2017.

S. J. Nevitt, M. Sudell, and J. Weston, Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Cochrane Database Syst Rev, vol.6, p.11412, 2017.

G. Coppola and G. Auricchio, Lamotrigine versus Valproic Acid as First-Line Monotherapy in Newly Diagnosed Typical Absence Seizures: An Open-Label, Randomized, Parallel-Group Study, Epilepsia, 2004.

V. Giri and . Prakash, Valproic Acid versus Lamotrigine as First-Line Monotherapy in Newly Diagnosed Idiopathic Generalized Tonic -Clonic Seizures in Adults -A Randomized Controlled Trial, J Clin Diagn Res, vol.10, issue.7, pp.1-4, 2016.

M. Pavlovi?, N. Jovi?, and T. Pekmezovi?, Antiepileptic drugs withdrawal in patients with idiopathic generalized epilepsy, Seizure, vol.20, issue.7, pp.520-525, 2011.

R. S. Fisher and C. Acevedo, ILAE Official Report: A Practical Clinical Definition of Epilepsy, Epilepsia, vol.55, issue.4, pp.475-82, 2014.

A. T. Berg, S. Shinnar, and F. M. Testa, Mortality in childhood-onset epilepsy, Arch Pediatr Adolesc Med, vol.158, issue.12, pp.1147-52, 2004.

L. Nashef, E. L. So, P. Ryvlin, and T. Tomson, Unifying the definitions of sudden unexpected death in epilepsy, Epilepsia, vol.53, issue.2, pp.227-260, 2012.

O. Abdel-mannan, H. Taylor, and E. J. Donner, A systematic review of sudden unexpected death in epilepsy (SUDEP) in childhood, Epilepsy Behav, 2019.

C. Harden, T. Tomson, and D. Gloss, Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the, Neurology, vol.88, issue.17, pp.1674-1680, 2017.

K. Nickels, Seizure and Psychosocial Outcomes of Childhood and Juvenile Onset Generalized Epilepsies: Wolf in Sheep's Clothing, or Well-Dressed Wolf? Epilepsy Curr, vol.15, pp.114-121, 2015.

N. Akanuma and E. Hara, Psychiatric Comorbidity in Adult Patients with Idiopathic Generalized Epilepsy, Epilepsy & Behavior, vol.13, issue.1, pp.248-51, 2008.

A. Jacoby, G. A. Baker, N. Steen, P. Potts, and D. W. Chadwick, The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study, Epilepsia, vol.37, issue.2, pp.148-61, 1996.

R. F. Chin, P. M. Cumberland, and S. S. Pujar, Outcomes of childhood epilepsy at age 33 years: a population-based birth-cohort study, Epilepsia, 2011.

P. R. Camfield and C. S. Camfield, What happens to children with epilepsy when they become adults? Some facts and opinions, Pediatr Neurol, vol.51, issue.1, pp.17-23, 2014.

F. Schneider-von-podewils, C. Gasse, and J. Geithner, Clinical predictors of the long-term social outcome and quality of life in juvenile myoclonic epilepsy: 20-65 years of follow-up, Epilepsia, vol.55, issue.2, pp.322-352, 2014.

. Serment-d'hippocrate,

, Au moment d'être admise à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité

, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux, individuels et sociaux

, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte

, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences

, Je ne me laisserai pas influencer par la soif du gain ou la recherche de la gloire

, Admise dans l'intimité des personnes, je tairai les secrets qui me seront confiés. Reçue à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs

, Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément

, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses ; que je sois déshonorée et méprisée si j'y manque